Hims & Hers Health, Inc. (HIMS) vs TransMedics Group, Inc. (TMDX)

TMDX leads on 9 of 12 compared metrics.

A side-by-side comparison of Hims & Hers Health, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total return — HIMS vs TMDX

growth of $100 · last 7y
HIMS +261.9%TMDX +228.6%HIMS compounded faster
0200400600Start $100202120232025$362$329
HIMS TMDX

HIMS vs TMDX: by the numbers

  • HIMS is the larger company ($7.91B vs $2.72B market cap).
  • TMDX is profitable (27.04% net margin) while HIMS runs a net loss (-0.56%).
  • TMDX grew revenue faster over the past five years (90.79% vs 69.19% CAGR).

Which is better, HIMS or TMDX?

Metric tally: HIMS 3 · TMDX 9

It depends on what you're optimizing for:

GrowthTMDX(faster 5Y revenue CAGR)
QualityTMDX(higher ROIC)

Metrics side by side

Valuation

MetricHIMSTMDX
P/E ratio18.03
Forward P/E75.3038.89
P/S ratio3.424.48
P/B ratio18.155.77
PEG ratio0.05
EV / EBITDA299.7523.28
FCF yield0.94%5.31%

Profitability

MetricHIMSTMDX
Gross margin67.64%59.09%
Operating margin1.32%14.85%
Net margin-0.56%27.04%
ROE-2.97%34.80%
ROIC6.02%10.94%

Growth (annualized)

MetricHIMSTMDX
Revenue CAGR (5Y)69.19%90.79%
Total return CAGR (5Y)26.16%21.48%

Frequently asked

Which is better, HIMS or TMDX?
It depends on your goal. growth: TMDX (faster 5Y revenue CAGR); quality: TMDX (higher ROIC). Across all compared metrics, TMDX leads 9 to 3.
Which has grown faster, HIMS or TMDX?
Over the past five years, TMDX grew revenue faster — HIMS at a 69.19% CAGR versus TMDX at 90.79%.
Is HIMS or TMDX more profitable?
TMDX runs the higher net margin — HIMS at -0.56% versus TMDX at 27.04%.
Which has been the better investment, HIMS or TMDX?
Over the past 5-year, HIMS delivered the higher annualized total return — HIMS at 26.16% versus TMDX at 21.48%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 20, 2026.